Abstract
Background: Gastric ulcer develops from imbalance of gastro-aggressive and protective factors. As existing drugs have adverse effects, use of natural products is in continuous expansion. In this study, we prepared nanoformulation with catechin and polylactide-co-glycolide to provide a sustained, controlled and targeted delivery. Materials & methods: Detailed characterization and toxicity study of nanoparticles were done on cells and Wistar rats. The comparative actions of free compound and nanocapsule were investigated in vitro and in vivo during treatment of gastric injury. Results: Nanocatechin improved bioavailability, reduced gastric damage at a significantly lower dose (2.5 mg/kg) by safeguarding from reactive oxygen species, restored mitochondrial integrity and downregulated MMP-9 and other inflammatory mediators. Conclusion: Nanocatechin is a better alternative for preventing and healing gastric ulcers.
Plain language summary
Gastric ulcer, a chronic disease, has a widespread effect on the global populace. Side effects become an issue with available drugs, so natural products are getting acceptance. A promising nanodrug has been designed with catechin, the primary component of green tea, to offer enhanced potency at a lower dose. Toxicity and efficacy studies on laboratory rats have shown its suitability for biological use. In our experimental model of gastric ulcer in rats, nanocatechin was given as drug. It showed improved absorption and relatively fast healing without any adverse impacts. Molecular-level research demonstrated its role in restoring mitochondrial integrity. Thus, it may be an alternative choice for treating stomach ulcers in the clinical setting.
Graphical abstract
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options. J. Clin. Med. 8(2), 179 (2019).
- 2. The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study. BMC Gastroenterol. 22(1), 58 (2022).
- 3. . Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Clin. Med. (Lond.) 21(2), 131–134 (2021).
- 4. . Effects of nonsteroidal anti-inflammatory drugs at the molecular level. Eurasian J. Med. 50(2), 116–121 (2018).
- 5. . Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 135(1), 41–60 (2008). • Depicts the molecular details of NSAID-associated gastric mucosal injury and the inherent defence.
- 6. . Gaseous mediators as a key molecular targets for the development of gastrointestinal-safe anti-inflammatory pharmacology. Front. Pharmacol. 12, 657457 (2021).
- 7. . The role of catechins in cellular responses to oxidative stress. Molecules 23(4), 965 (2018).
- 8. . Catechins and their therapeutic benefits to inflammatory bowel disease. Molecules 22(3), 484 (2017).
- 9. Bioavailability of tea catechins and its improvement. Molecules 23(9), 2346 (2018).
- 10. Impact of gastrointestinal physiology on drug absorption in special populations – an UNGAP review. Eur. J. Pharm. Sci. 147, 105280 (2020).
- 11. Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnol. 16(1), 71 (2018).
- 12. . Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20(2), 101–124 (2021).
- 13. . Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 94(3), 909–950 (2014).
- 14. . The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults. Oxid. Med. Cell. Longev. 2016, 3164734 (2016).
- 15. . Scavenging of reactive oxygen and nitrogen species with nanomaterials. Nano. Res. 11(10), 4955–4984 (2018).
- 16. . Cytochrome c release from mitochondria proceeds by a two-step process. Proc. Natl Acad. Sci. USA 99(3), 1259–1263 (2002).
- 17. ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy. Cell Res. 22(7), 1181–1198 (2012).
- 18. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci. Signal. 4(167), ra20 (2011).
- 19. . A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity. Biomed. Mater. 5(6), 065002 (2010).
- 20. . Preparation and characterisation of nanoparticles containing ketoprofen and acrylic polymers prepared by emulsion solvent evaporation method. J. Exp. Nanosci. 7(2), 189–197 (2012).
- 21. . In vitro and in vivo studies on vitamin E TPGS-emulsified poly (D, L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials 27(10), 2285–2291 (2006).
- 22. . Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193(1), 265–275 (1951). • Protein estimation, required for most of the techniques including gelatin zymography and western blotting, was carried out following the method of Lowry et al.
- 23. . Comparative research of anti-inflammatory effects of different dietary antioxidants on alcohol-induced damage in gastric cells. Free Radic. Antioxid. 9(1), 16–21 (2019).
- 24. Ministry of Environment, Forest and Climate Change (MoEF&CC), Govt. of India. Compendium of CPCSEA (2018). https://cpcsea.nic.in/WriteReadData/userfiles/file/Compendium%20of%20CPCSEA.pdf
- 25. Organisation for Economic Cooperation and Development (OECD). Guideline for Testing of Chemicals No. 423. Acute Oral Toxicity – Acute Toxic Class Method (2001). • The universally accepted guideline for testing acute oral toxicity in rodents for any chemicals.
- 26. Encapsulation of the flavonoid quercetin with an arsenic chelator into nanocapsules enables the simultaneous delivery of hydrophobic and hydrophilic drugs with a synergistic effect against chronic arsenic accumulation and oxidative stress. Free Radic. Biol. Med. 51(10), 1893–1902 (2011). • Forms the basis of this study that nanoencapsuled natural products delivers the drug to target cells with a much faster rate than that of free components.
- 27. Mitochondrial toxicity and antioxidant activity of a prenylated flavonoid isolated from Dalea elegans. Chem. Biol. Interact. 171(3), 294–305 (2008).
- 28. . Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol. 105, 331–337 (1984).
- 29. . Changes in glutathione and cellular energy as potential mechanisms of papaverine-induced hepatotoxicity in vitro. Toxicol. Appl. Pharmacol. 108(1), 28–36 (1991).
- 30. Measuring myeloperoxidase activity in biological samples. PLOS ONE 8(7), e67976 (2013).
- 31. . Methods for detection of mitochondrial and cellular reactive oxygen species. Antioxid. Redox. Signal. 20(2), 372–382 (2014).
- 32. Neuroprotective effect of osmotin against ethanol-induced apoptotic neurodegeneration in the developing rat brain. Cell Death Dis. 5, e1150 (2014).
- 33. In-vivo and in-vitro toxicity test of molecularly engineered PCMS: a potential drug for wireless remote controlled treatment. Toxicol. Rep. 5, 1044–1052 (2018).
- 34. Indomethacin impairs mitochondrial dynamics by activating the PKCζ-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells. J. Biol. Chem. 294(20), 8238–8258 (2019).
- 35. Malabaricone C attenuates nonsteroidal anti-inflammatory drug-induced gastric ulceration by decreasing oxidative/nitrative stress and inflammation and promoting angiogenic autohealing. Antioxid. Redox. Signal. 32(11), 766–784 (2020).
- 36. . New insights in intestinal oxidative stress damage and the health intervention effects of nutrients: a review. J. Functional Foods 75, 104248 (2020).
- 37. . Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J. Neurosci. Res. 74(6), 801–806 (2003).
- 38. . Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Future Cardiol. 8(6), 863–884 (2012).
- 39. . The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine. J. Clin. Biochem. Nutr. 48(2), 107–111 (2011). •• Illustrates the basis of choosing NSAID-mediated-induced gastric ulcer model.
- 40. . NSAIDs downregulate Bcl-X(L) and dissociate BAX and Bcl-X(L) to induce apoptosis in colon cancer cells. Nutr. Cancer 60, 98–103 (2008).
- 41. . Is mPTP the gatekeeper for necrosis, apoptosis, or both? Biochim. Biophys. Acta 1813(4), 616–622 (2011).
- 42. . Mechanisms of action of Bcl-2 family proteins. Cold Spring Harb. Perspect. Biol. 5(4), a008714 (2013).